BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 10438458)

  • 21. Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death.
    Robaszkiewicz A; Erdélyi K; Kovács K; Kovács I; Bai P; Rajnavölgyi E; Virág L
    Free Radic Biol Med; 2012 Oct; 53(8):1552-64. PubMed ID: 22940495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional overexpression of human poly(ADP-ribose) polymerase in transfected rat tumor cells.
    Bernges F; Bürkle A; Küpper JH; Zeller WJ
    Carcinogenesis; 1997 Apr; 18(4):663-8. PubMed ID: 9111197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of apoptosis of a PARP(-)/(-)cell line transfected with PARP DNA-binding domain mutants.
    Aoufouchi S; Yélamos J; Milstein C
    J Mol Biol; 1999 Jul; 290(5):943-9. PubMed ID: 10438594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(ADP ribose) polymerase cleavage precedes neuronal death in the hippocampus and cerebellum following injury to the developing rat forebrain.
    Joashi UC; Greenwood K; Taylor DL; Kozma M; Mazarakis ND; Edwards AD; Mehmet H
    Eur J Neurosci; 1999 Jan; 11(1):91-100. PubMed ID: 9987014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo supplementation with nicotinic acid enhances cellular poly(ADP-ribosyl)ation and improves cell viability in human peripheral blood mononuclear cells.
    Weidele K; Kunzmann A; Schmitz M; Beneke S; Bürkle A
    Biochem Pharmacol; 2010 Oct; 80(7):1103-12. PubMed ID: 20599792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosis.
    Affar EB; Germain M; Winstall E; Vodenicharov M; Shah RG; Salvesen GS; Poirier GG
    J Biol Chem; 2001 Jan; 276(4):2935-42. PubMed ID: 11053413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribosyl)ation regulates heat shock factor-1 activity and the heat shock response in murine fibroblasts.
    Fossati S; Formentini L; Wang ZQ; Moroni F; Chiarugi A
    Biochem Cell Biol; 2006 Oct; 84(5):703-12. PubMed ID: 17167533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase.
    Yakovlev AG; Wang G; Stoica BA; Boulares HA; Spoonde AY; Yoshihara K; Smulson ME
    J Biol Chem; 2000 Jul; 275(28):21302-8. PubMed ID: 10807908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.
    Pétrilli V; Herceg Z; Hassa PO; Patel NS; Di Paola R; Cortes U; Dugo L; Filipe HM; Thiemermann C; Hottiger MO; Cuzzocrea S; Wang ZQ
    J Clin Invest; 2004 Oct; 114(8):1072-81. PubMed ID: 15489954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and proliferation of cells expressing caspase-uncleavable Poly(ADP-ribose) polymerase in response to death-inducing DNA damage by an alkylating agent.
    Halappanavar SS; Rhun YL; Mounir S; Martins LM; Huot J; Earnshaw WC; Shah GM
    J Biol Chem; 1999 Dec; 274(52):37097-104. PubMed ID: 10601269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal trauma model: in search of Thanatos.
    Cole K; Perez-Polo JR
    Int J Dev Neurosci; 2004 Nov; 22(7):485-96. PubMed ID: 15465278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H(2)O(2) injury.
    Cole KK; Perez-Polo JR
    J Neurochem; 2002 Jul; 82(1):19-29. PubMed ID: 12091461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment.
    He J; Whitacre CM; Xue LY; Berger NA; Oleinick NL
    Cancer Res; 1998 Mar; 58(5):940-6. PubMed ID: 9500454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly (ADP-ribose) polymerase induction is an early signal of apoptosis in human neuroblastoma.
    Bursztajn S; Feng JJ; Berman SA; Nanda A
    Brain Res Mol Brain Res; 2000 Mar; 76(2):363-76. PubMed ID: 10762713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress.
    Decker P; Muller S
    Curr Pharm Biotechnol; 2002 Sep; 3(3):275-83. PubMed ID: 12164482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.